BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Talecris Biotherapeutics (TLCR) Announces Results of Annual Stockholders' Meeting


5/3/2011 9:58:06 AM

RESEARCH TRIANGLE PARK, N.C., May 3, 2011 /PRNewswire/ -- Talecris Biotherapeutics Holdings Corp. (NASDAQ: TLCR) held its annual meeting of stockholders today in Chapel Hill, N.C., where four proposals were submitted to, and approved by, stockholders.

Stockholders elected three directors to the company's Board of Directors to hold office for a three-year term until the annual meeting of stockholders in 2014, and until their successors are elected and qualified. The three directors are W. Brett Ingersoll, Lawrence D. Stern and Ruedi E. Waeger, PhD.

Stockholders also ratified the appointment of PricewaterhouseCoopers LLP as the company's independent, registered, public accounting firm for the fiscal year ending December 31, 2011.

In a pair of advisory and non-binding votes, stockholders approved the compensation of the company's named executive officers and recommended holding an advisory vote every three years on compensation of the company's named executive officers.

A replay of the meeting will be available beginning at 1 p.m. EDT and will remain accessible until May 10, 2011, by dialing 1-888-286-8010 (domestic) or 1-617-801-6888 (international). The pass code is 86974301. The webcast of the meeting call will be archived on the Investor Relations section of http://www.talecris.com.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.

SOURCE Talecris Biotherapeutics Holdings Corp.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES